1. Allolio B, Keffel D, Deuss U, Winkelmann W (1985) Behandlung sexueller Verhaltensstörungen mit LH-RH Superagonisten. Deut Med Wochenschr 110:1952
2. Basdekis-Jozsa R, Turner D, Briken P (2013) Pharmacological treatment of sexual offenders and its legal and ethical aspects. In: Harrison K, Rainey B (Hrsg) The Wiley-Blackwell handbook of legal and ethical aspects of sex offender treatment and management. John Wiley & Sons, Chichester, S 302–320
3. Berner W, Hill A, Briken P, Kraus C, Lietz K (2007) DGPPN Leitlinien: Störungen der Sexualpräferenz. Steinkopff, Darmstadt
4. Boer DP, Hart S, Kropp P, Webster C (1997) Manual for sexual violence risk-20. Professional guidelines for assessing risk of sexual violence. Mental Health, Law, and Policy Institute Simon Fraser University, Burnaby
5. Bradford JM (2001) The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behaviour. Can J Psychiatry 46:26–34.
https://doi.org/10.1177/070674370104600104